A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793) Research Letter
| Authors: | Bellone, S.; Roque, D. M.; Siegel, E. R.; Buza, N.; Hui, P.; Bonazzoli, E.; Guglielmi, A.; Zammataro, L.; Nagarkatti, N.; Zaidi, S.; Lee, J.; Silasi, D. A.; Huang, G. S.; Andikyan, V.; Damast, S.; Clark, M.; Azodi, M.; Schwartz, P. E.; Tymon-Rosario, J.; Harold, J.; Mauricio, D.; Zeybek, B.; Menderes, G.; Altwerger, G.; Ratner, E.; Alexandrov, L. B.; Iwasaki, A.; Kong, Y.; Song, E.; Dong, W.; Elvin, J.; Choi, J.; Santin, A. D. |
| Title: | A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793) |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | 8 |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-08-01 |
| Start Page: | 1045 |
| End Page: | 1046 |
| Language: | English |
| DOI: | 10.1016/j.annonc.2021.04.013 |
| PUBMED: | 33932502 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 2 August 2021 -- Source: Scopus |
